Cheng Li

Stock Analyst at Oppenheimer

(n/a)
# 4,755
Out of 5,045 analysts
2
Total ratings
n/a
Success rate
-31.6%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Cheng Li

Wave Life Sciences
Jul 28, 2025
Initiates: Outperform
Price Target: $24
Current: $8.26
Upside: +190.56%
Vaxart
Aug 15, 2024
Initiates: Outperform
Price Target: $4
Current: $0.35
Upside: +1,038.95%